D-0577-2026 Class II Ongoing
FDA drug recall D-0577-2026 was initiated by Guardian Drug Co. Inc. on May 28, 2026 and is designated Class II. Reason for recall: Presence of foreign substance: small metallic particles in chewable tablets. The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 10, 2026
- Initiation Date
- May 28, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
EQUALINE ultra strength, antacid tablets, calcium carbonate 1000mg, 72 chewable tablets, DISTRIBUTED BY SUPERVALU INC.,EDEN PRARIE, MN 55344 USA, NDC 41163-171-68.
Reason for recall
Presence of foreign substance: small metallic particles in chewable tablets.
Distribution pattern
U.S.A. Nationwide
Code information
Lot #: 1716089, expires: JAN- 2029.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0577-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026